Table 1:
Peripheral Artery Disease | Marginal Inclusion Probability | Uncorrected p-value |
FDR-corrected p-value |
---|---|---|---|
ApoB | 0.856 | 0.003 | 0.015 |
ApoA1 | 0.529 | 0.025 | 0.052 |
HDL-C | 0.467 | 0.031 | 0.052 |
LDL-C | 0.461 | 0.168 | 0.21 |
Triglycerides | 0.238 | 0.386 | 0.386 |
Coronary Artery Disease | |||
ApoB | 0.922 | 0.005 | 0.027 |
HDL-C | 0.457 | 0.022 | 0.054 |
LDL-C | 0.33 | 0.746 | 0.746 |
ApoA1 | 0.284 | 0.123 | 0.206 |
Triglycerides | 0.152 | 0.58 | 0.726 |
Ranking of most likely causal exposures amongst major lipoproteins for peripheral artery disease and coronary artery disease prioritized using multivariable Mendelian randomization in the Mendelian randomization Bayesian Model Averaging (MR-BMA) framework. False discovery rate (FDR) corrected p-values are derived in an empirical permutation procedure. LDL-C: low-density lipoprotein cholesterol, HDL-C: high-density lipoprotein cholesterol, ApoA1: apolipoprotein A1, ApoB: apolipoprotein B.